Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.620
+0.010 (0.62%)
Nov 21, 2024, 4:00 PM EST - Market closed
Standard BioTools Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -124.59 | -74.66 | -190.1 | -59.24 | -53.02 | -64.79 | Upgrade
|
| Depreciation & Amortization | 5.61 | 3.98 | 3.5 | 3.65 | 6.03 | 4.61 | Upgrade
|
| Other Amortization | 11.97 | 11.97 | 12.36 | 12.54 | 12.46 | 13.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.21 | 0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 3.53 | - | - | 0.44 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.98 | - | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 27.74 | 13.12 | 14.88 | 16.1 | 14.45 | 11.39 | Upgrade
|
| Other Operating Activities | -22.19 | 0.51 | 81.95 | 2.81 | 2.04 | 13.51 | Upgrade
|
| Change in Accounts Receivable | -1.4 | -2.99 | 1.06 | 6.73 | -7.63 | -2.08 | Upgrade
|
| Change in Inventory | -16.57 | -4.91 | -8.47 | -4.78 | -8.64 | -3.05 | Upgrade
|
| Change in Accounts Payable | -10.79 | 1.62 | -2.78 | 1.28 | 3.36 | 0.79 | Upgrade
|
| Change in Unearned Revenue | -2.91 | 0.88 | -3.47 | -3.21 | 2.11 | 2.13 | Upgrade
|
| Change in Other Net Operating Assets | -4.37 | 7.19 | -1.83 | -19.95 | 13.21 | -11.39 | Upgrade
|
| Operating Cash Flow | -143.46 | -43.29 | -89.37 | -44.06 | -15.42 | -35.21 | Upgrade
|
| Capital Expenditures | -5.05 | -2.83 | -3.83 | -13.26 | -12.72 | -2.53 | Upgrade
|
| Cash Acquisitions | 280.03 | - | - | - | -5.15 | - | Upgrade
|
| Investment in Securities | 49.35 | 23.07 | -84.3 | - | 36.81 | -36.77 | Upgrade
|
| Other Investing Activities | - | - | - | 1.32 | 21.04 | - | Upgrade
|
| Investing Cash Flow | 324.33 | 20.24 | -88.13 | -11.95 | 39.98 | -39.3 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 6.84 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 25 | 10 | - | 55 | Upgrade
|
| Total Debt Issued | - | - | 25 | 16.84 | - | 55 | Upgrade
|
| Long-Term Debt Repaid | - | -2.08 | -6.84 | -0.5 | - | -51.83 | Upgrade
|
| Net Debt Issued (Repaid) | -9.44 | -2.08 | 18.16 | 16.34 | - | 3.17 | Upgrade
|
| Issuance of Common Stock | 1.97 | 0.83 | 0.92 | 1.49 | 22 | 2.13 | Upgrade
|
| Repurchase of Common Stock | -41.08 | -5.55 | -0.77 | -1.79 | -0.46 | -0.63 | Upgrade
|
| Other Financing Activities | -0.55 | - | -12.55 | -0.08 | -0.68 | -1.89 | Upgrade
|
| Financing Cash Flow | -49.1 | -6.81 | 230.76 | 15.96 | 20.86 | 2.79 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.29 | 0.03 | -0.4 | -0.02 | 0.39 | 0.06 | Upgrade
|
| Net Cash Flow | 131.49 | -29.83 | 52.86 | -40.07 | 45.8 | -71.67 | Upgrade
|
| Free Cash Flow | -148.51 | -46.12 | -93.2 | -57.33 | -28.13 | -37.74 | Upgrade
|
| Free Cash Flow Margin | -95.26% | -43.37% | -95.15% | -43.90% | -20.37% | -32.19% | Upgrade
|
| Free Cash Flow Per Share | -0.53 | -0.58 | -1.19 | -0.76 | -0.39 | -0.57 | Upgrade
|
| Cash Interest Paid | 3.29 | 3.82 | 3.49 | 3.15 | 3.09 | 3.54 | Upgrade
|
| Cash Income Tax Paid | 0.58 | 0.8 | 0.31 | 2.09 | 0.52 | 0.21 | Upgrade
|
| Levered Free Cash Flow | -66.16 | -8.5 | -34.2 | -31.59 | -5.31 | -20.82 | Upgrade
|
| Unlevered Free Cash Flow | -64.08 | -6.42 | -32.33 | -29.82 | -3.62 | -20.08 | Upgrade
|
| Change in Net Working Capital | 28.63 | -7.51 | 1.42 | 6.07 | -8.6 | 12.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.